Molecular Signatures of High-Grade Cervical Lesions
Cervical cancer is the fourth most common neoplasia in women and the infection with human papilloma virus (HPV) is its necessary cause. Screening methods, currently based on cytology and HPV DNA tests, display low specificity/sensitivity, reducing the efficacy of cervical cancer screening programs....
Main Authors: | Andreia M. Porcari, Fernanda Negrão, Guilherme Lucas Tripodi, Denise Rocha Pitta, Elisabete Aparecida Campos, Douglas Munhoz Montis, Aline M. A. Martins, Marcos N. Eberlin, Sophie F. M. Derchain |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2018.00099/full |
Similar Items
-
Analysis of the application values of different combination schemes of liquid-based cytology and high-risk human papilloma virus test in the screening of high-grade cervical lesions
by: Jian Wang
Published: (2018-11-01) -
Incidence, trends and histopathological pattern of cervical malignancies at BP Koirala Memorial cancer hospital, Nepal.
by: TB Pathak, et al.
Published: (2013-03-01) -
Efficacy in Treatment of Cervical HrHPV Infection by Combination of Beta Interferon, and Herbal Therapy in Woman with Different Cervical Lesions
by: Ermina Iljazović, et al.
Published: (2008-11-01) -
Laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS) as a metabolomics platform in cervical cancer screening
by: Maria Paraskevaidi, et al.
Published: (2020-10-01) -
RISK FACTORS OF PRE-CANCER CERVICAL DISEASES IN WOMEN OF REPRODUCTIVE AGE
by: O.A. Dyndar, et al.
Published: (2020-02-01)